| 000 | 03212cam a2200781 a 4500 | ||
|---|---|---|---|
| 001 | ocn772774190 | ||
| 003 | OCoLC | ||
| 005 | 20171224113811.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 120113s2012 enk ob 001 0 eng | ||
| 010 | _a 2012002010 | ||
| 040 |
_aDLC _beng _epn _cDLC _dDG1 _dN$T _dYDXCP _dE7B _dNLGGC _dNLE _dCN3GA _dEBLCP _dOCLCQ _dOCLCO _dOCLCQ _dDEBBG _dOCLCQ |
||
| 019 | _a860515116 | ||
| 020 |
_a9781118301913 _q(MobiPocket) |
||
| 020 |
_a1118301919 _q(MobiPocket) |
||
| 020 |
_a9781118302057 _q(Adobe PDF) |
||
| 020 |
_a1118302052 _q(Adobe PDF) |
||
| 020 |
_a9781118302064 _q(ePub) |
||
| 020 |
_a1118302060 _q(ePub) |
||
| 020 |
_a9781118301906 _q(electronic bk.) |
||
| 020 |
_a1118301900 _q(electronic bk.) |
||
| 020 |
_z9781119967262 _q(pbk.) |
||
| 029 | 1 |
_aAU@ _b000048454846 |
|
| 029 | 1 |
_aDEBBG _bBV041069164 |
|
| 029 | 1 |
_aDEBBG _bBV042795963 |
|
| 029 | 1 |
_aNZ1 _b15915757 |
|
| 029 | 1 |
_aNZ1 _b16242848 |
|
| 029 | 1 |
_aDEBBG _bBV043393977 |
|
| 035 |
_a(OCoLC)772774190 _z(OCoLC)860515116 |
||
| 042 | _apcc | ||
| 050 | 0 | 0 | _aRM301.25 |
| 060 | 1 | 0 | _aQZ 42 |
| 072 | 7 |
_aMED _x072000 _2bisacsh |
|
| 082 | 0 | 0 |
_a615/.4 _223 |
| 049 | _aMAIN | ||
| 100 | 1 | _aOrleans-Lindsay, Justina. | |
| 245 | 1 | 0 |
_aPharmacovigilance medical writing : _ba good practice guide / _cJustina Orleans-Lindsay. |
| 260 |
_aChichester, West Sussex, UK : _bWiley Blackwell, _c2012. |
||
| 300 | _a1 online resource. | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aPharmacovigilance medical writing : an overview across the drug development process -- Pharmacovigilance medical writing for clinical trials -- Pharmacovigilance medical writing for CTD submissions -- Pharmacovigilance medical writing in risk evaluation & management -- Pharmacovigilance medical writing for marketed products -- The Ad-Hoc safety review & response to questions document -- The rest of the world. | |
| 588 | 0 | _aPrint version record and CIP data provided by publisher. | |
| 650 | 0 | _aPharmacoepidemiology. | |
| 650 | 0 | _aWriting. | |
| 650 | 0 | _aDrug monitoring. | |
| 650 | 0 |
_aCommunication in medicine _xMethodology. |
|
| 650 | 2 | _aPharmacoepidemiology. | |
| 650 | 2 | _aWriting. | |
| 650 | 2 | _aDrug Monitoring. | |
| 650 | 2 |
_aHealth Communication _xmethods. |
|
| 650 | 2 |
_aPharmaceutical Preparations _xadverse effects. |
|
| 650 | 2 | _aProduct Surveillance, Postmarketing. | |
| 650 | 7 |
_aMEDICAL _xPharmacy. _2bisacsh |
|
| 655 | 4 | _aElectronic books. | |
| 776 | 0 | 8 |
_iPrint version: _aOrleans-Lindsay, Justina. _tPharmacovigilance medical writing. _dChichester, West Sussex, UK : John Wiley & Sons Inc., 2012 _z9781119967262 _w(DLC) 2012001218 |
| 856 | 4 | 0 |
_uhttp://onlinelibrary.wiley.com/book/10.1002/9781118301906 _zWiley Online Library |
| 938 |
_aEBL - Ebook Library _bEBLB _nEBL4033962 |
||
| 938 |
_aebrary _bEBRY _nebr10653579 |
||
| 938 |
_aEBSCOhost _bEBSC _n465211 |
||
| 938 |
_aYBP Library Services _bYANK _n8917852 |
||
| 938 |
_aYBP Library Services _bYANK _n9341132 |
||
| 938 |
_aYBP Library Services _bYANK _n8923620 |
||
| 994 |
_a92 _bDG1 |
||
| 999 |
_c11510 _d11510 |
||